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Toward a Better Understanding of...

PIK3C2G in Multiform Glioblastoma
Patrick Nils Lasowski
Mentor: Milan Chheda
Multiform Glioblastoma (GBM) is an aggressive, malignant cancer which affects glial
cells, most commonly in the brain. There are currently no curative treatments available
for GBM. It is thought that GBM tumor initiating cells (TICs) strongly contribute to
GBM’s aggressive and malignant nature. Tumor initiating cells are known for their
plasticity, resistance to treatment, self-renewing capabilities, and tumorigenic properties.
Knowing more about the specific genes involved in the genetic pathways common to
GBM could provide information beneficial to the eventual development of effective
GBM therapies. Previous experiments targeting genes amplified in GBM have shown
that the knock down of PIK3C2G results in decreased relative cell counts. Additionally,
previous experiments have shown that suppression of PIK3C2G in TICs resulted in cell
differentiation and cell death. Other previous experiments have focused on PIK3C2G’s
role in insulin signaling in hepatic cells. Little is currently known about PIK3C2G’s
role in the brain or elsewhere in the body outside of in the insulin signaling pathway
in hepatic cells. In order to investigate the potential proto-oncogenic properties of
PIK3C2G, we designed knock down and over expression experiments in a transformed
cancer cell line and murine NIH 3T3 cell lines respectively. The designed experiments
involve immunoblotting, immunoprecipitation, quantitative PCR, sub-cloning DNA,
and shRNA-mediated gene suppression. Initially, we chose to use the gateway system for
the overexpression experiment due to its flexibility. However, after concerns regarding
potentially low levels of expression when using the gateway system’s destination vectors,
we settled on using the retroviral vector pBABE-puro instead. Following previous
complications, the final stages of this experiment are still underway.
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